Cue Biopharma, Inc. (CUE)
USD 1.07
(0.94%)
USD 1.07
(0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 5.49 Million | 1.24 Million | 14.94 Million | 3.15 Million | 3.45 Million | 1.14 Million |
| Cost of Revenue | 38.09 Million | 1.8 Million | -1.77 Million | 33.54 Million | 27.48 Million | 28.54 Million |
| Gross Profit | -32.6 Million | -560.82 Thousand | 16.71 Million | -30.39 Million | -24.02 Million | -27.4 Million |
| Operating Expenses | 19.54 Million | 54.74 Million | 58.65 Million | 48.19 Million | 40.22 Million | 39.83 Million |
| Selling, General and Administrative Expenses | 16.68 Million | 16.16 Million | 17.3 Million | 14.65 Million | 12.74 Million | 11.29 Million |
| Research and Development Expenses | 40.8 Million | 38.57 Million | 41.34 Million | 33.54 Million | 27.48 Million | 28.54 Million |
| Other Expenses | -37.94 Million | - | - | - | 64 Thousand | 165.33 Thousand |
| Cost and Expenses | 57.63 Million | 54.74 Million | 58.65 Million | 48.19 Million | 40.22 Million | 39.83 Million |
| Operating Income | -52.14 Million | -53.22 Million | -43.71 Million | -45.04 Million | -36.76 Million | -38.69 Million |
| Interest Expense | 1.24 Million | 713.81 Thousand | - | - | - | - |
| Income Tax Expense | - | -214.42 Thousand | 495 Thousand | 206.25 Thousand | 412 Thousand | 825 Thousand |
| Earnings before Tax | -50.73 Million | -53.01 Million | -43.66 Million | -44.57 Million | -36.28 Million | -38.15 Million |
| Net Income | -50.73 Million | -52.79 Million | -44.16 Million | -44.78 Million | -36.69 Million | -38.98 Million |
| Earnings Per Share Basic | -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 |
| Earnings Per Share Diluted | -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 |
| Weighted Average Shares Outstanding | 45.75 Million | 35.64 Million | 31.28 Million | 28.68 Million | 22.04 Million | 20.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.75 Million | 35.64 Million | 31.28 Million | 28.68 Million | 22.04 Million | 20.13 Million |
| Gross Margin | -5.94 | -0.45 | 1.12 | -9.63 | -6.95 | -23.98 |
| EBIT Margin | -8.39 | -40.77 | -2.93 | -13.94 | -10.63 | -33.20 |
| Profit Margin | -9.24 | -42.40 | -2.96 | -14.20 | -10.61 | -34.12 |
| EBITDA | -46.05 Million | -50.49 Million | -45.44 Million | -43.98 Million | -35.95 Million | -37.93 Million |
| Earnings Before Tax Margin | -9.50 | -42.74 | -2.93 | -14.28 | -10.63 | -33.87 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.65 Million | 1.71 Million | 1.82 Million | 5.49 Million | 2.1 Million | 1.38 Million |
| Cost of Revenue | 866 Thousand | 849 Thousand | 851 Thousand | 3.43 Million | 857 Thousand | 848 Thousand |
| Gross Profit | 1.79 Million | 868 Thousand | 970 Thousand | 2.05 Million | 1.24 Million | 534 Thousand |
| Operating Expenses | 12.17 Million | 13.53 Million | 14.64 Million | 54.04 Million | 13.51 Million | 14.89 Million |
| Selling, General and Administrative Expenses | 2.64 Million | 3.33 Million | 3.85 Million | - | 3.64 Million | 4.24 Million |
| Research and Development Expenses | 9.53 Million | 10.19 Million | 10.78 Million | - | 9.87 Million | 10.65 Million |
| Other Expenses | -9.53 Million | - | - | - | - | - |
| Cost and Expenses | 13.04 Million | 14.38 Million | 15.49 Million | 57.48 Million | 13.51 Million | 14.89 Million |
| Operating Income | -10.38 Million | -12.66 Million | -13.67 Million | -51.99 Million | -11.41 Million | -13.51 Million |
| Interest Expense | 215 Thousand | 241 Thousand | 507 Thousand | 1.24 Million | 286 Thousand | 232 Thousand |
| Income Tax Expense | - | 805.72 Thousand | 807.18 Thousand | 3.26 Million | 700 Thousand | 564 Thousand |
| Earnings before Tax | -10.17 Million | -12.34 Million | -13.43 Million | -50.73 Million | -11 Million | -13.18 Million |
| Net Income | -10.17 Million | -12.34 Million | -13.43 Million | -50.73 Million | -11 Million | -13.18 Million |
| Earnings Per Share Basic | -0.20 | -0.25 | -0.28 | - | -0.24 | -0.29 |
| Earnings Per Share Diluted | -0.20 | -0.25 | -0.28 | - | -0.24 | -0.29 |
| Weighted Average Shares Outstanding | 50.17 Million | 49.46 Million | 47.14 Million | 45.75 Million | 46.35 Million | 44.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.17 Million | 49.46 Million | 47.14 Million | 45.75 Million | 46.35 Million | 44.79 Million |
| Gross Margin | 0.67 | 0.51 | 0.53 | 0.37 | 0.59 | 0.39 |
| EBIT Margin | -3.58 | -6.88 | -7.04 | - | -4.70 | -8.76 |
| Profit Margin | -3.83 | -7.19 | -7.38 | -9.24 | -5.24 | -9.54 |
| EBITDA | -9.51 Million | -11.81 Million | -12.82 Million | - | -9.86 Million | -12.1 Million |
| Earnings Before Tax Margin | -3.91 | -7.38 | -7.51 | -9.47 | -5.44 | -9.78 |
2327
SCDA
BEKS
4076
ORA
MEXGF